New study suggests COVID-19 immunity is 'waning,' researchers say


A free daily digest of the biggest news stories of the day - and the best features from our website
Thank you for signing up to TheWeek. You will receive a verification email shortly.
There was a problem. Please refresh the page and try again.
Researchers in the United Kingdom say they've observed a "significant" decline in the percentage of the population with COVID-19 antibodies, potentially pointing to "waning immunity."
Imperial College London scientists in the study found the prevalence of COVID-19 antibodies declined from six percent of the British population in June to 4.4 percent in September, Reuters reports. They came to the conclusion that there has been a "significant decline in the proportion of the population with detectable antibodies" by sending out finger-prick tests to a randomly selected group of over 365,000 people in England, according to CNN.
"On the balance of evidence I would say, with what we know for other coronaviruses, it would look as if immunity declines away at the same rate as antibodies decline away, and that this is an indication of waning immunity at the population level," Wendy Barclay, head of Imperial College London's Department of Infectious Disease, said, per Reuters.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The researchers were specifically looking for IgG antibodies in the study, and CNN notes that some other research has suggested "that other types of antibodies may persist longer than IgG does."
But Imperial College London's Helen Ward told BBC News the study suggests that "immunity is waning quite rapidly." Ward added in a statement, "We don't yet know whether this will leave these people at risk of reinfection with the virus that causes COVID-19, but it is essential that everyone continues to follow guidance to reduce the risk to themselves and others."
Continue reading for free
We hope you're enjoying The Week's refreshingly open-minded journalism.
Subscribed to The Week? Register your account with the same email as your subscription.
Sign up to our 10 Things You Need to Know Today newsletter
A free daily digest of the biggest news stories of the day - and the best features from our website
Brendan is a staff writer at The Week. A graduate of Hofstra University with a degree in journalism, he also writes about horror films for Bloody Disgusting and has previously contributed to The Cheat Sheet, Heavy, WhatCulture, and more. He lives in New York City surrounded by Star Wars posters.
-
FDA to re-evaluate effectiveness of common nasal congestion ingredient
Speed Read
By Justin Klawans Published
-
A flesh-eating bacteria is growing in numbers due to climate change
Speed Read
By Devika Rao Published
-
CDC recommends new RSV vaccine for infants under 8 months
Speed Read
By Devika Rao Published
-
U.S. health agency advises easing federal marijuana restrictions
Speed Read
By Peter Weber Published
-
Medicare drug price negotiations start with 1st 10 drugs, pharmaceutical industry lawsuits
Speed Read
By Peter Weber Published
-
Air pollution may be increasing antibiotic resistance, new research suggests
Speed Read
By Devika Rao Published
-
Tick bites could cause an allergy to red meat, CDC says
Speed Read
By Devika Rao Published
-
The danger of drinking too much water
Speed Read
By Devika Rao Published